Abstract
Background and Purpose: Platelet-to-neutrophil ratio (PNR) was suggested to be an independent protective predictor for 90-days outcomes in acute ischemic stroke (AIS) patients in previous studies. This study aims to investigate the association between PNR and outcomes of AIS in intravenous thrombolysis (IVT) group.
Methods: Data on acute ischemic stroke patients who received intravenous thrombolysis from April 2015 to March 2019 were collected. We defined the PNR value at admission as pre-IVT PNR and after IVT within 24 h was defined as post-IVT PNR. Clinical outcome indicators included early neurological deterioration (END), hemorrhagic transformation (HT), delayed neurological deterioration (DND), and poor 3-month outcome (3m-mRS >2).
Results: A total of 581 patients were enrolled in the final analysis. The age was 61(53-69) years, and 423(72.8%) were males. Post-IVT PNR was independently associated with hemorrhagic transformation (OR = 0.974; 95%CI = 0.956-0.992; P=0.006), early neurological deterioration (OR = 0.939; 95%CI = 0.913-0.966; P = 0.01), delayed neurological deterioration (OR = 0.949; 95%CI = 0.912- 0.988; P = 0.011), and poor outcome (OR = 0.962; 95%CI = 0.948-0.976; P<0.001). PNR level was identified as high (at the cut-off value or above) or low (below the cut-off value) according to receiver operating curve (ROC) analyses on each endpoint. Comparison of early neurological deterioration, hemorrhagic transformation, delayed neurological deterioration, and poor 3-month outcome (3m-mRS >2) between patients at high and low levels for platelet-to-neutrophil ratio (PNR) showed statistical differences (p<0.001).
Conclusion: Post-IVT PNR was independently associated with early neurological deterioration, hemorrhagic transformation, delayed neurological deterioration, and poor 3-month outcome. Lower PNR can predict a worse outcome.
Keywords: Acute ischemic stroke, intravenous thrombolysis, early neurological deterioration, hemorrhagic transformation, delayed neurological deterioration.
[http://dx.doi.org/10.1111/ene.13409] [PMID: 28800170]
[http://dx.doi.org/10.2174/1389450117666160818115850] [PMID: 27538508]
[http://dx.doi.org/10.1016/S1357-2725(96)00122-7] [PMID: 9076944]
[http://dx.doi.org/10.1055/s-0035-1564835] [PMID: 26926581]
[http://dx.doi.org/10.1007/s10555-017-9677-x] [PMID: 28667366]
[http://dx.doi.org/10.1182/blood.V88.1.146.146] [PMID: 8704169]
[PMID: 9843183]
[http://dx.doi.org/10.1189/jlb.0910538] [PMID: 21097697]
[http://dx.doi.org/10.1038/nri3399] [PMID: 23435331]
[http://dx.doi.org/10.1038/jcbfm.2015.45] [PMID: 25806703]
[http://dx.doi.org/10.1097/MD.0000000000010180] [PMID: 29561432]
[http://dx.doi.org/10.1016/j.jocn.2019.01.028] [PMID: 30737090]
[http://dx.doi.org/10.1097/MD.0000000000010493] [PMID: 29703010]
[http://dx.doi.org/10.1007/s00401-014-1381-0] [PMID: 25548073]
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.06.018] [PMID: 26169549]
[http://dx.doi.org/10.1016/j.jacc.2003.08.039] [PMID: 14736451]
[http://dx.doi.org/10.1212/WNL.0b013e3182897015] [PMID: 23486872]
[http://dx.doi.org/10.1212/WNL.0000000000004982] [PMID: 29367438]
[http://dx.doi.org/10.1212/WNL.0000000000002029] [PMID: 26362283]